aDepartment of Pathology and Laboratory Medicine, University of Calgary Cumming School of Medicine and Alberta Precision Laboratories, Calgary, AB, Canada
bDepartment of Medical Oncology, Faculty of Medicine and Dentistry, University of Alberta, and Alberta Health Services-Cancer Control, Edmonton, AB, Canada
cDepartments of Human Genetics and Urology, University of California, Los Angeles, CA, USA
dDepartment of Urology, Vattikuti Urology Institute, Henry Ford Health System Detroit, MI, USA
eTom Baker Cancer Centre, Calgary, AB, Canada
fDepartments of Oncology, Biochemistry and Molecular Biology, University of Calgary Cumming School of Medicine, Calgary, AB, Canada
gArnie Charbonneau Cancer Institute, Calgary, AB, Canada
hDepartment of Pathology, Faculty of Medicine, Mansoura University, Egypt, 35512 Mansoura, Egypt
⁎Corresponding author at: Departments of Pathology & Laboratory Medicine and Oncology, Rockyview General Hospital, Calgary, Alberta T2V 1P9, Canada. Tel. +1 (403) 943-8430; Fax: +1 (403) 943-3333. tabismar@ucalgary.ca